Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30939096

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Aug 1
First author
Tolaney SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Nov 1;37(31):2954-2955. doi: 10.1200/JCO.19.01822.
    note
    Source null
    related pmid
    31518173
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Nov 1;37(31):2953-2954. doi: 10.1200/JCO.19.01299.
    note
    Source null
    related pmid
    31518177
    relationship
    Comment in

Authors and identifiers

  1. name
    Tolaney SM
    type
    Author
  2. name
    Guo H
    type
    Author
  3. name
    Pernas S
    type
    Author
  4. name
    Barry WT
    type
    Author
  5. name
    Dillon DA
    type
    Author
  6. name
    Ritterhouse L
    type
    Author
  7. name
    Schneider BP
    type
    Author
  8. name
    Shen F
    type
    Author
  9. name
    Fuhrman K
    type
    Author
  10. name
    Baltay M
    type
    Author
  11. name
    Dang CT
    type
    Author
  12. name
    Yardley DA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tolaney SM
    type
    Author
  2. name
    Guo H
    type
    Author
  3. name
    Pernas S
    type
    Author
  4. name
    Barry WT
    type
    Author
  5. name
    Dillon DA
    type
    Author
  6. name
    Ritterhouse L
    type
    Author
  7. name
    Schneider BP
    type
    Author
  8. name
    Shen F
    type
    Author
  9. name
    Fuhrman K
    type
    Author
  10. name
    Baltay M
    type
    Author
  11. name
    Dang CT
    type
    Author
  12. name
    Yardley DA
    type
    Author
bibliography ids
  1. nci-bib-96a524b0141469c3cb17749a
book metadata
content sha256
5521a120657b19a3d108764917fc71cc7ead2b4e37bcdf391ee6a0965639245c
document type
citation
dois
  1. 10.1200/JCO.19.00066
electronic publication date
display
2019 Apr 2
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30939096
immutable id
pubmed:30939096@5521a120657b19a3d108764917fc71cc7ead2b4e37bcdf391ee6a0965639245c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
22
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1868-1875
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Nov 1;37(31):2954-2955. doi: 10.1200/JCO.19.01822.
    note
    Source null
    related pmid
    31518173
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Nov 1;37(31):2953-2954. doi: 10.1200/JCO.19.01299.
    note
    Source null
    related pmid
    31518177
    relationship
    Comment in
outcomes validated
false
pmid
30939096
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
c6a82766345f989c749ca116363a7ef1b9b9cc99c08c280d49bbb5f98a94be9c
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Aug 1
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30939096/
title
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Preserved source evidence · Not medical advice